Stock Price Quote

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE337.45-5.85 (-1.7 %)
PREV CLOSE ( ) 343.30
OPEN PRICE ( ) 345.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 124692
TODAY'S LOW / HIGH ( )326.15 353.00
52 WK LOW / HIGH ( )110 374.5
NSE338.00-5.25 (-1.53 %)
PREV CLOSE( ) 343.25
OPEN PRICE ( ) 349.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 338.00 (471)
VOLUME 741410
TODAY'S LOW / HIGH( ) 326.50 356.00
52 WK LOW / HIGH ( )109.3 374.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
Jai Hiremath - Chairman Jai Hiremath - Managing Director
Registered Office

Address 717 / 718,Maker Chambers V,Nariman Point,
Mumbai,
Maharashtra-400021

Phone 66301801 / 22834587

Email info@hikal.com

Website www.hikal.com

Registrars Details
Universal Capital Securities Pvt. Ltd
(Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas ,Opp. Satya Saibaba Temple, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE, MCX

NEWS

07May Cupid, Shri Bajrang Alliance and Vedan
Cupid has received purchase order from Uttar Pradesh Medical Supplies Co..
07May Hikal informs about press release
Hikal has informed that it has enclosed a copy of the Press Release on 7..
06May Hikal informs about outcome of board m
Hikal has informed that Board of Directors of the Company at its meeting..
06May Hikal reports 2- fold jump in Q4 net p
Hikal has reported results for fourth quarter and year ended March 31, 2..
06May Appointment of Director
Inter alia, has appproved the recommendation of Final Dividend for the f..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit509.21331.5
Gross Profit 806.1 2064.3
Operating Profit 1121.33278.7
Net Sales 5324.617204.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Hester Biosciences (BSE)
peergroup  2470.05 (11.53%)
M.Cap ( in Cr)2101.24
Astrazeneca Pharma I (BSE)
peergroup  3840.05 (2.70%)
M.Cap ( in Cr)9600.13
Themis Medicare (BSE)
peergroup  497.30 (6.82%)
M.Cap ( in Cr)456.94
Caplin Point Lab (BSE)
peergroup  591.05 (4.82%)
M.Cap ( in Cr)4470.86
Glaxosmithkline Phar (BSE)
peergroup  1503.80 (1.65%)
M.Cap ( in Cr)25475.28

Shareholding Pattern

PROMOTERS 68.77%
NON-INSTITUTION 24.73%
MUTUAL FUNDS/UTI 0.45%
FI/BANKS/INSURANCE 0.12%
GOVERNMENT 0%
FII 0%

About Hikal Ltd.

Hikal Ltd. was incorporated in the year 1988. Its today's share price is 337.45. Its current market capitalisation stands at Rs 4160.78 Cr. In the latest quarter, company has reported Gross Sales of Rs. 15072.63 Cr and Total Income of Rs.15109.65 Cr. The company's management includes Rajasekhar Reddy, Sugandha Hiremath, Shivani Bhasin Sachdeva, Ranjit Shahani, Kannan Unni, Ravindra Kumar Goyal, Prakash Mehta, Amit Kalyani, Baba Kalyani, Sameer Hiremath, Jai Hiremath, Jai Hiremath.

It is listed on the BSE with a BSE Code of 524735 , NSE with an NSE Symbol of HIKAL and ISIN of INE475B01022. It's Registered office is at 717 / 718,Maker Chambers V,Nariman PointMumbai-400021, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BSR & Co, BSR & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)